Daniel C. Chung (85, 88) is a senior research investigator/adjunct assistant professor of ophthalmology at the FM Kirby Center for Molecular Ophthalmology of the Scheie Eye Institute at the University of Pennsylvania School of Medicine and Clinical Advisor in the Children’s Hospital of Philadelphia Retinal Gene Therapy Clinical Trial Team for Childhood Blindness. He endeavors to find gene-based cures for blindness secondary to inherited retinal disease in children and adults, and to characterize their disease in the clinic. Recently, the CHOP gene therapy team has been the first to successfully restore vision in children with a blinding congenital disease.
He received a BS in Biology in 1985 and the MA in Family Counseling in 1988 from ENC and went on to the New York College of Osteopathic Medicine from 1990-1994. Dan was then selected as an Intramural Research Training Award Fellow at the National Eye Institute/National Institutes of Health in Bethesda, Maryland, for work in ocular gene therapy. He went on to an internship and residency in ophthalmology in Akron, Ohio and completed a clinical fellowship in pediatric ophthalmology and a research fellowship in ocular genetics at the Cleveland Clinic Foundation. He has published numerous papers, abstracts and reviews, presents annually at national meetings, has been an invited lecturer both nationally and internationally, and holds grants from foundations and the National Institutes of Health. He is a member of the ENC Alumni Council and ENC Board of Trustees, serving on the Executive committee and chairing the Committee for Enrollment and Marketing. Dan has served faithfully in a number of Nazarene churches in many different capacities. He and wife, Patti (Long, 88) have 3 children, Benjamin, Christopher and Emma.